Welcome to our dedicated page for The Pennant Group news (Ticker: PNTG), a resource for investors and traders seeking the latest updates and insights on The Pennant Group stock.
The Pennant Group, Inc. (NASDAQ: PNTG) is an established healthcare provider in the United States, serving patients of all ages with a particular focus on the growing senior population. The company operates in multiple segments including home health, hospice, and senior living services. Pennant Group’s senior living services comprise assisted living, independent living, and memory care facilities located across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming.
The company derives a significant portion of its revenue from its home health and hospice segments, which collectively include home health, hospice, and home care services. These services are designed to provide comprehensive and compassionate care to individuals in the comfort of their homes, enhancing their quality of life and supporting their families.
In recent developments, Pennant Group formed a strategic joint venture with John Muir Health to create Muir Home Health, a new entity aimed at delivering home health services throughout the Bay Area. This collaboration leverages John Muir Health’s extensive healthcare expertise and Pennant Group’s profound experience in home health management. The venture is set to offer a range of services including skilled nursing, physical therapy, occupational and speech therapy, home health aide, and medical social work services.
Pennant Group is committed to innovation and quality care, backed by its operational model that empowers local leadership teams to implement effective clinical programs and ensure seamless transitional care. The company's leadership underscores their dedication to providing exceptional patient care and supporting their employees, as evidenced by the glowing remarks from both Pennant Group and John Muir Health executives regarding the new joint venture.
Financially, the company continues to maintain a solid performance, with ongoing projects and partnerships designed to expand its service delivery and enhance patient outcomes. Investors and stakeholders can stay informed about the latest updates by tuning into their scheduled conference calls and webcasts, the next of which is slated for May 7, 2024, at 10:00 am MT.
The Pennant Group (NASDAQ: PNTG) has completed its acquisition of Signature Healthcare at Home assets in Oregon, following the earlier purchase of Signature's Idaho and Washington assets on August 1, 2024. The Oregon acquisition, finalized on January 1, 2025, includes seven locations across the state, complementing Pennant's existing presence in Portland and Grant's Pass.
This two-stage acquisition strengthens Pennant's position as a leading home health and hospice provider in the Pacific Northwest. The company reports a successful integration of the Idaho and Washington operations over the previous two quarters, with management expressing confidence in the cultural alignment between the organizations. Following what they describe as a record-breaking year in 2024, Pennant now operates 122 home health and hospice agencies and 57 senior living communities across 13 states.
The Pennant Group (NASDAQ: PNTG) has announced key leadership changes to its board of directors, effective January 1, 2025. Brent Guerisoli, the company's current CEO since 2022, has been appointed as Chairman of the board, succeeding Barry Smith who will remain on the board and continue as chairman of the nominating and corporate governance committee.
Additionally, Scott Lamb has been appointed as Lead Independent Director. Lamb, who has served on Pennant's board and as chairman of its audit committee since 2019, brings valuable experience from his previous role as CFO of ICU Medical (2008-2020). Guerisoli, who has been with the organization since 2012 and joined the board in 2023, has been recognized for his inspiring leadership, consistent performance, and transparent communication.
The Pennant Group (NASDAQ: PNTG) announced its participation in the 2024 Stephens Annual Investment Conference, scheduled for November 19-20, 2024. The company's leadership team, including CEO Brent Guerisoli, CFO Lynette Walbom, and President/COO John Gochnour, will engage in a fireside chat on November 19 at 10:00 a.m. Central Time. Pennant Group, which operates affiliated home health, hospice and senior living companies, will provide a live webcast of the event through their investor relations website.
Pennant Group (NASDAQ: PNTG) reported strong Q3 2024 results with total revenue of $180.7 million, up 28.9% year-over-year. Net income reached $6.2 million, increasing 41.6%, while adjusted earnings per share was $0.26. Home Health and Hospice Services segment revenue grew 33.7% to $135.7 million, with total home health admissions up 38.5%. Senior Living Services segment revenue increased 16.3% to $45.0 million. The company updated its 2024 guidance, projecting total revenue between $665.3-706.5 million and adjusted earnings per share of $0.90-0.96.
The Pennant Group (NASDAQ: PNTG) has acquired three senior living facilities in Green Bay and Appleton, Wisconsin, effective November 1, 2024. The acquisition includes Marla Vista Assisted Living and Manor (renamed to Blue Jay Springs Senior Living and Memory Care), Carrington Assisted Living (renamed to Autumn Embers Senior Living), and Carolina Assisted Living (renamed to Lotus Gardens Senior Living). The transaction adds 125 units to Pennant's portfolio and will operate under a long-term, triple net lease arrangement. This strategic move strengthens Pennant's presence in Wisconsin and enhances its ability to serve the region's growing senior population.
The Pennant Group (NASDAQ: PNTG) has announced its plans to release third quarter 2024 financial results on November 6, 2024. The company will host a live webcast on November 7, 2024, at 10:00 a.m. Mountain Time to discuss the results. Investors can access the webcast through the Investor Relations section of Pennant's website. The recorded webcast will be available for replay until November 6, 2025.
Pennant Group is a holding company operating 122 home health and hospice agencies and 54 senior living communities across 13 states. These healthcare services are provided through independent operating subsidiaries, each with its own management and assets.
The Pennant Group (NASDAQ: PNTG) announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at $31.00 per share, aiming to raise $108.5 million before deducting underwriting discounts, commissions, and expenses. The underwriters have a 30-day option to purchase an additional 525,000 shares. The company plans to use the net proceeds to repay outstanding debt under its revolving credit facility and for general corporate purposes. The offering is expected to close around October 4, 2024, subject to customary conditions. Citigroup and Truist Securities are the lead book-running managers, with Wells Fargo Securities and RBC Capital Markets as joint book-running managers. Oppenheimer & Co. and Stephens Inc. are co-managers. The offering is being made under an effective shelf registration statement filed with the SEC. A preliminary prospectus supplement was filed on September 30, 2024, and the final prospectus supplement will be filed with the SEC.
The Pennant Group (NASDAQ: PNTG) has announced a public offering of 3,500,000 shares of common stock. The company plans to grant underwriters a 30-day option to purchase up to 525,000 additional shares. Proceeds will be used to repay outstanding debt under the company's revolving credit facility, with any remaining funds allocated for general corporate purposes.
Citigroup and Truist Securities are lead book-running managers, while Wells Fargo Securities and RBC Capital Markets are joint book-running managers. Oppenheimer & Co. and Stephens Inc. are acting as co-managers. The offering is being made pursuant to the company's effective shelf registration statement filed with the SEC.
The Pennant Group (NASDAQ: PNTG) reported strong Q2 2024 results, with total revenue increasing 27.6% to $168.7 million and net income rising 103.4% to $5.7 million. Key highlights include:
- Home Health and Hospice segment revenue up 31.9% to $125.3 million
- Senior Living Services segment revenue increased 16.6% to $43.4 million
- Total home health admissions grew 35.4% to 14,140
- Hospice average daily census rose 29.1% to 3,220
The company updated its 2024 guidance, projecting total revenue between $654.0 million and $694.5 million, and adjusted earnings per diluted share between $0.89 and $0.95. Pennant's CEO attributed the strong performance to mature operations and robust acquisition activity.
The Pennant Group (NASDAQ: PNTG) has completed the acquisition of Signature Healthcare at Home's Washington and Idaho assets. This marks the first phase of a larger acquisition, with Signature's Oregon business set to close on January 1, 2025. The acquisition strengthens Pennant's presence in Idaho and expands its footprint in Washington, a critical certificate of need state.
Pennant's CEO, Brent Guerisoli, highlighted the acquisition as a significant milestone in the company's investment in the Pacific Northwest. The company plans to implement its unique operating model, innovative technology, and best practices to enhance the quality of care in the acquired operations. This strategic move is expected to complement Pennant's existing operations and leverage its high-performing leaders in the region.
FAQ
What is the current stock price of The Pennant Group (PNTG)?
What is the market cap of The Pennant Group (PNTG)?
What services does The Pennant Group, Inc. provide?
Where are The Pennant Group, Inc.'s services available?
What recent partnerships has The Pennant Group, Inc. entered into?
What are the primary sources of revenue for The Pennant Group, Inc.?
When is the next conference call for The Pennant Group, Inc.?
What does the new joint venture Muir Home Health offer?
Who will manage the joint venture Muir Home Health?
How does The Pennant Group, Inc. support its local leadership teams?
What is the goal of the joint venture between The Pennant Group and John Muir Health?
How can investors stay updated on The Pennant Group, Inc.’s activities?
